Mankind Pharma Limited Ofloxacin Export Data — India (DGFT 2022–2026)

Name: Mankind Pharma Limited Ofloxacin Export Records India — #9 Exporter, 160 Shipments, $6.1M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Ofloxacin

India Pharmaceutical Trade Intelligence

$295.2M1,094 Suppliers180 CountriesHS 30049099

ExportsIndia → UNITED STATES39.2%India → VIETNAM6.8%

ImportsMALTA → India$59.6M CHINA → India$17.1M

#1 Buyer: DR REDDYS

Mankind Pharma Limited — Ofloxacin Exporter #9 | $6.1M Trade Value | TransData Nexus | TransData Nexus

Mankind Pharma Limited — Ofloxacin Exporter Profile

Indian Pharmaceutical Exporter · #9 for Ofloxacin · $6.1M export value · DGFT Verified

Mankind Pharma Limited is the #9 Indian exporter of Ofloxacin with $6.1M in export value and 160 verified shipments. Mankind Pharma Limited holds a 2.1% market share in Ofloxacin exports across 3 countries. The company exports 15 pharmaceutical products worth $58.3M across 10 therapeutic categories.

Mankind Pharma Limited — Ofloxacin Export Profile: Buyers & Destinations

Mankind Pharma Limited Ofloxacin export treemap — buyers and destination countries | TransData Nexus

Where Does Mankind Pharma Limited Export Ofloxacin?

Country	Value	Shipments	Share
UNITED STATES	$8.4M	256	99.6%
PAKISTAN	$23.6K	2	0.3%
AFGHANISTAN	$11.6K	4	0.1%
UNITED ARAB EMIRATES	$255	4	0.0%
IRAQ	$126	2

Who Are the Top Buyers of Ofloxacin from Mankind Pharma Limited?

Buyer	Country	Value	Orders
LIFESTAR PHARMA LLC	UNITED STATES	$5.6M	170
LIFESTAR PHARMA LLC.	UNITED STATES	$1.5M	46
LIFESTAR PHARMA LLC...	UNITED STATES	$696.8K	19
NORTHSTAR DISTRIBUTION CENTER 8912,	UNITED STATES	$400.0K	16
NORTHSTAR DISTRIBUTION CENTER 8912	UNITED STATES	$227.7K	5
ZAHIR HADROGUL LTD.	PAKISTAN	$25.8K	3
ZAHIR HADROGUL LTD	AFGHANISTAN	$9.5K	3
ZMC EXPRESS CARGO FZCO	IRAQ	$381	6

Mankind Pharma Limited supplies Ofloxacin to 8 buyers globally. The largest buyer is LIFESTAR PHARMA LLC (UNITED STATES), followed by LIFESTAR PHARMA LLC. (UNITED STATES) and LIFESTAR PHARMA LLC... (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Ofloxacin Formulations Does Mankind Pharma Limited Export?

Product Description / Formulation	Value	Shipments
OFLOXACIN OPHTHALMIC SOLUTION,USP 0.3%(5	$585.9K	15
OFLOXACIN OTIC SOLUTION 0.3% (10ML FILL)	$299.8K	18
OFLOXACIN OTIC SOLUTION 0.3% 10ML FILL	$222.1K	8
OFLOXACIN OPHTHALMIC SOLUTION,USP 0.3%5	$150.0K	3
OFLOXACIN OTIC SOLUTION 0.3% (5ML FILL)H	$140.2K	3
OFLOXACIN OTIC SOLUTION 0.3% (10MLFILL)	$119.7K	5
OFLOXACIN OTIC SOLUTION 0.3% (5ML FILL)	$118.8K	8
OFLOXACIN OPHTHALMIC SOLUTION, USP 0.3%(5ML IN 10ML BOTTLE FILL) (NET CONT. 0.5076 KGS)[BATCH NO. B3X019 MFG. DT. 03/24	$117.3K	3
OFLOXACIN OPHTHALMIC SOLUTION, USP 0.3%(5ML IN 10ML BOTTLE FILL) (NET CONT. 0.50976 KGS)[BATCH NO. B3X023 MFG. DT. 04/2	$117.0K	3
OFLOXACIN OPHTHALMIC SOLUTION, USP 0.3%(5ML IN 10ML BOTTLE FILL) (NET CONT. 0.50976 KGS)[BATCH NO. B3X025 MFG. DT. 04/2	$117.0K	3

Mankind Pharma Limited exports 135 distinct Ofloxacin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is OFLOXACIN OPHTHALMIC SOLUTION,USP 0.3%(5 with 15 shipments worth $585.9K.

How Does Mankind Pharma Limited Compare to Nearest Ofloxacin Exporters?

Exporters ranked immediately above and below #9 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
6	AUROBINDO PHARMA LTD	$7.2M	172	12	$42.0K
7	SENTISS PHARMA PRIVATE LIMITED	$6.3M	130	7	$48.7K
9	MANKIND PHARMA LIMITED ★	$6.1M	160	3	$38.4K
10	FDC LIMITED	$5.5M	110	5	$50.0K
1	DR.REDDY'S LABORATORIES LTD	$3.7M	74	2	$50.0K

Mankind Pharma Limited ranks #9 among 1094 Indian Ofloxacin exporters. Average shipment value of $38.4K compared to the market average of $65.6K. The closest competitors by value are AUROBINDO PHARMA LTD and SENTISS PHARMA PRIVATE LIMITED.

Which Indian Ports Ship Ofloxacin Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	1,841	12.3%
DELHI AIR CARGO ACC (INDEL4)	1,504	10.0%
SAHAR AIR	1,292	8.6%
NHAVA SHEVA SEA (INNSA1)	1,262	8.4%
DELHI AIR	894	6.0%
Bombay Air	655	4.4%
JNPT/ NHAVA SHEVA SEA	645	4.3%
Delhi Air	361	2.4%

Geopolitical & Trade Policy Impact on Mankind Pharma Limited's Ofloxacin Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Mankind Pharma. The Israel-Iran conflict has led to increased tensions in the Red Sea, resulting in higher shipping costs and potential delays for exporters relying on these routes. Additionally, Houthi attacks in the region have further exacerbated shipping disruptions, impacting the timely delivery of pharmaceutical products.

Conversely, ongoing US-China trade tensions have prompted the United States to diversify its import sources, creating opportunities for Indian pharmaceutical companies to capture a larger share of the US market. Mankind Pharma's established presence and compliance with international quality standards position it favorably to leverage this shift.

In the European Union, stringent regulatory changes, such as the Falsified Medicines Directive, necessitate robust compliance measures. Mankind Pharma's commitment to quality and recent strategic initiatives, including the acquisition of BSV, enhance its ability to meet these evolving standards and maintain a competitive edge in the EU market.

Mankind Pharma Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for pharmaceutical exporters. Mankind Pharma's adherence to guidelines set by the FDA, WHO, and EU GMP underscores its commitment to quality. The acquisition of BSV, known for its complex R&D platforms and biologics expertise, further strengthens Mankind Pharma's compliance capabilities, ensuring alignment with global quality requirements. (mankindpharma.com)

The evolving regulatory landscape, particularly in the EU with directives like the Falsified Medicines Directive, demands continuous adaptation. Mankind Pharma's proactive approach, including investments in advanced manufacturing and quality assurance systems, positions it well to navigate these changes and sustain its export growth.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Ofloxacin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Mankind Pharma Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 268 individual customs records matching Mankind Pharma Limited exporting Ofloxacin, covering 135 formulations to 5 countries via 8 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 180+ countries, 3,093+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Ofloxacin

Ofloxacin

Mankind Pharma Limited — Ofloxacin Exporter Profile

Mankind Pharma Limited — Ofloxacin Export Profile: Buyers & Destinations

Where Does Mankind Pharma Limited Export Ofloxacin?

Who Are the Top Buyers of Ofloxacin from Mankind Pharma Limited?

What Is India's Total Ofloxacin Export Value and How Much Does Mankind Pharma Limited Contribute?

What Is the Average Shipment Value for Mankind Pharma Limited's Ofloxacin Exports?

How Does Mankind Pharma Limited Compare to Other Indian Ofloxacin Exporters?

What Ofloxacin Formulations Does Mankind Pharma Limited Export?

Regulatory Requirements: Exporting Ofloxacin to Key Markets

United States — FDA

How Does Mankind Pharma Limited Compare to Nearest Ofloxacin Exporters?

Which Indian Ports Ship Ofloxacin Exports?

What Other Advanced Antibiotics Products Does Mankind Pharma Limited Export?

Geopolitical & Trade Policy Impact on Mankind Pharma Limited's Ofloxacin Exports

Mankind Pharma Limited — Regulatory Compliance & Quality Standards

About Mankind Pharma Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Ofloxacin Export Data from Mankind Pharma Limited

Ofloxacin Stats

Company Overview

Top Products by Mankind Pharma Limited

Related Analysis

Need Detailed Export Data?

Data Source